compound

Mazdutide (5mg Vial) Questions Answered

Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.

Read full protocol Calculate dose Find supplies TNHL ebooks

Educational reference only. TNHL does not diagnose, prescribe, or replace care from a licensed professional. Confirm all dosing, contraindications, and product decisions with qualified guidance.

Direct answer

Mazdutide (5mg Vial)

Week Weekly Dose Units (per injection) (mL) Weeks 1–4 2.5 mg (2,500 mcg) 150 units (1.50 mL) Weeks 5–8+ 5 mg (5,000 mcg) 300 units (3.00 mL) Frequency: Inject once weekly subcutaneously.

Quickstart Highlights

Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.

Standard / Gradual Titration (3.0 mL = ~1.67 mg/mL)

Week Weekly Dose Units (per injection) (mL) Weeks 1–4 2.5 mg (2,500 mcg) 150 units (1.50 mL) Weeks 5–8+ 5 mg (5,000 mcg) 300 units (3.00 mL) Frequency: Inject once weekly subcutaneously.

Supplies Needed

Plan based on an 8–16 week weekly protocol with gradual titration to 5 mg maintenance.